Mannose-binding lectin is a regulator of inflammation that accompanies myocardial ischemia and reperfusion injury

Journal of Immunology

Volumn 175, Issue 1, 2005, Pages 541-546

  Walsh, Mary C ^a   Bourcier, Todd ^a   Takahashi, Kazue ^b   Shi, Lei ^b   Busche, Marc N ^a   Rother, Russell P ^c   Solomon, Scott D ^a   Ezekowitz, R Alan B ^b   Stahl, Gregory L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c ALEXION PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MANNOSE BINDING LECTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPLEMENT CLASSICAL PATHWAY; CONTROLLED STUDY; HEART MUSCLE ISCHEMIA; INFLAMMATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY;

EID: 21244496324     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.1.541     Document Type: Article

References (41)

1. Hill, J. H., and P. A. Ward. 1971. The phlogistic role of C3 leukotactic fragments in myocardial infarcts in rats. J. Exp. Med. 133: 885-900.
2. Walport, M. J. 2001. Complement: first of two parts. N. Engl. J. Med. 344: 1058-1066.
3. Walport, M. J. 2001. Complement: second of two parts. N. Engl. J. Med. 344: 1140-1144.
4. Weisman, H. F., T. Bartow, M. K. Leppo, H. C. Marsh, Jr., G. R. Carson, M. F. Concino, M. P. Boyle, K. H. Roux, M. L. Weisfeldt, and D. T. Fearon. 1990. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 249: 146-151.
5. Pemberton, M., G. Anderson, V. Vetvicka, D. E. Justus, and G. D. Ross. 1993. Microvascular effects of complement blockade with soluble recombinant CR1 on ischemia/reperfusion injury of skeletal injury. J. Immunol. 150: 5104-5113.
6. Wada, K., M. C. Montalto, and G. L. Stahl. 2001. Inhibition of complement C5 reduces local and remote organ injury after intestinal ischemia/reperfusion in the rat. Gastroenterology. 120: 126-133.
7. Zhao, H., M. C. Montalto, K. J. Pfeifer, L. Hao and G. L. Stahl. 2002. Murine model of gastrointestinal ischemia associated with complement-dependent injury. J. Appl. Physiol. 93: 338-345.
8. Stahl, G. L.; Y. Xu, L. Hao, M. Miller, J. A. Buras, M. Fung, and H. Zhao. 2003. Role for the alternative complement pathway in ischemia/reperfusion injury. Am. J. Pathol. 162: 449-455.
9. Karpel-Massler, G., S. D. Fleming, M. Kirschfink, and G. C. Tsokos. 2003. Human c1 esterase inhibitor attenuates murine mesenteric ischemia/reperfusion induced local organ injury. J. Surg. Res. 115: 247-256.
10. Korb, L. C., and J. M. Ahearn. 1997. C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited. J. Immunol. 158: 4525-4528.
11. Mevorach, D. 2000. Opsonization of apoptotic cells: implications for uptake and autoimmunity. Ann. NY Acad. Sci. 926: 226-235.
12. Fishelson, Z., G. Attali, and D. Mevorach. 2001. Complement and apoptosis. Mol. Immunol. 38: 207-219.
13. Holmskov, U., S. Thiel, and J. C. Jensenius. 2003. Collections and ficolins: humoral lectins of the innate immune defense. Annu. Rev. Immunol. 21: 547-578.
14. Zhang, M., W. G. Austen, Jr., I. Chiu, E. M. Alicot, R. Hung, M. Ma, N. Verna, M. Xu, H. B. Hechtman, F. D. Moore, Jr., and M. C. Carroll. 2004. Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia/reperfusion injury. Proc. Natl. Acad. Sci. USA 101: 3886-3891.
15. Collard, C. D., A. Vakeva, M. A. Morrissey, A. Agah, S. A. Rollins, W. R. Reenstra, J. A. Buras, S. Men, and G. L. Stahl. 2000. Complement activation after oxidative stress: role of the lectin complement pathway. Am. J. Pathol. 156: 1549-1556.
16. Jordan, J. E., M. C. Montalto, and G. L. Stahl. 2001. Inhibition of mannose-binding lectin reduces postischemic myocardial reperfusion injury. Circulation 104: 1413-1418.
17. Shi, L., K. Takahashi, J. Dundee, S. Shahroor-Karni, S. Thiel, J. C. Jensenius, F. Gad, M. R. Hamblin, K. N. Sastry, and R. A. Ezekowitz. 2004. Mannose-binding lectin-deficient mice are susceptible to infection with Staphylococcus aureus. J. Exp. Med. 199: 1379-1390.
18. Botto, M., C. Dell'Agnola, A. E. Bygrave, E. M. Thompson, H. T. Cook, F. Petry, M. Loos, P. P. Pandolfi, and M. J. Walport. 1998. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet. 19: 56-59.
19. Taylor, P. R., J. T. Nash, E. Theodoridis, A. E. Bygrave, M. J. Walport, and M. Botto. 1998. A targeted disruption of the murine complement factor B gene resulting in loss of expression of three genes in close proximity, factor B, C2, and D17H6S45. J. Biol. Chem. 273: 1699-1704.
20. Xu, Y., M. Ma, G. C. Ippolito, H. W. Schroeder, Jr., M. C. Carroll, and J. E. Volanakis. 2001. Complement activation in factor D-deficient mice. Proc. Natl. Acad. Sci. USA 98: 14577-14582.
21. Kenchaiah, S., M. A. Pfeffer, S. M. St John, T. Plappert, J. L. Rouleau, G. A. Lamas, Z. Sasson, J. O. Parker, E. M. Geltman, and S. D. Solomon. 2004. Effect of antecedent systemic hypertension on subsequent left ventricular dilation after acute myocardial infarction (from the Survival and Ventricular Enlargement trial). Am. J. Cardiol. 94: 1-8.
22. Vakeva, A., A. Agah, S. A. Rollins, L. A. Maus, L. Li, and G. L. Stahl. 1998. Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: role of the terminal complement components and inhibition by anti-C5 therapy. Circulation 97: 2259-2267.
23. Man, M. L., K. A. Ceonzo, L. A. Shaffer, K. Takahashi, L. Shi, W. R. Keenstra, J. A. Buras, R. A. B. Ezekowitz, and G. L. Stahl. 2005. Gastrointestinal ischemia-reperfusion injury is lectin complement pathway dependent without involving C1q. J. Immunol. 174: 6373-6380.
24. Kohro, S., Q. H. Hogan, Y. Nakae, M. Yamakage, and Z. J. Bosnjak. 2001. Anesthetic effects on mitochondrial ATP-sensitive K channel. Anesthesiology 95: 1435-1440.
25. Kehl, F., P. S. Pagel, J. G. Krolikowski, W. Gu, W. Toller, D. C. Warltier, and J. R. Kersten. 2002. Isoflurane does not produce a second window of preconditioning against myocardial infarction in vivo. Anesth. Analg. 95: 1162-1168.
26. Hu, G., T. Vasiliauskas, M. R. Salem, D. P. Rhone, and G. J. Crystal. 2003. Neutrophils pretreated with volatile anesthetics lose ability to cause cardiac dysfunction. Anesthesiology 98: 712-718.
27. Sahul, A., and J. D. Lambris. 2000. Complement inhibitors: a resurgent concept in anti-inflammatory therapeutics. Immunophannacology 49: 133-148.
28. Matsushita, M., S. Thiel, J. C. Jensenius, I. Terai, and T. Fujita. 2000. Proteolytic activities of two types of mannose-binding lectin-associated serine protease. J. Immunol. 165: 2637-2642.
29. Jiang, H. X., E. Wagner, H. M. Zhang, and M. M. Frank. 2001. Complement I inhibitor is a regulator of the alternative complement pathway. J. Exp. Med. 194: 1609-1616.
30. Wong, N. K., M. Kojima, J. Dobo, G. Ambrus, and R. B. Sim. 1999. Activities of the MBL-associated serine proteases (MASPs) and their regulation by natural inhibitors. Mol. Immunol. 36: 853-861.
31. Thiel, S., T. Vorup-Jensen, C. M. Stover, W. Schwaeble, S. B. Laursen, K. Poulsen, A. C. Willis, P. Eggleton, S. Hansen, U. Holmskov, et al. 1997. A second serine protease associated with mannan-binding lectin that activates complement. Nature 386: 506-510.
32. Rossen, R. D., L. H. Michael, A. Kagiyama, H. E. Savage, G. Hanson, M. A. Reisberg, J. N. Moake, S. H. Kim, D. Self, S. Weakley, et al. 1988. Mechanism of complement activation after coronary artery occlusion: evidence that myocardial ischemia in dogs causes release of constituents of myocardial subcellular origin that complex with human C1q in vivo. Circ. Res. 62: 572-584.
33. Buerke, M., T. Murohara, and A. M. Lefer. 1995. Cardioprotective effects of a C1 esterase inhibitor in myocardial ischemia and reperfusion. Circulation 91: 393-402.
34. Ogden, C. A., A. deCathelineau, P. R. Hoffmann, D. Bratton, B. Ghebrehiwet, V. A. Fadok, and P. M. Henson. 2001. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J. Exp. Med. 194: 781-795.
35. Stuart, L. M., K. Takahashi, L. Shi, J. Savill, and R. A. Ezekowitz. 2005. Mannose-binding lectin-deficient mice display defective apoptotic cell clearance but no autoimmune phenotype. J. Immunol. 174: 3220-3226.
36. Fliss, H., and D. Gattinger. 1996. Apoptosis in ischemic and reperfused rat myocardium. Circ. Res. 79: 949-956.
37. Peter, M. E., A. E. Heufelder, and M. O. Hengartner, 1997. Advances in apoptosis research. Proc. Natl. Acad. Sci. USA 94: 13736-13737.
38. Murphy, E. 2004. Inhibit GSK-3β or there's heartbreak dead ahead. J. Clin. Invest. 113: 1526-1528.
39. Juhaszova, M., D. B. Zorov, S. H. Kim, S. Pepe, Q. Fu, K. W. Fishbein, B. D. Ziman, S. Wang, K. Ytrehus, C. L. Antos, et al. 2004. Glycogen synthase kinase-3β mediates convergence of protection signaling to inhibit the mitochon-drial permeability transition pore. J. Clin. Invest. 113: 1535-1549.
40. Fiane, A. E., V. Videm, P. S. Lingaas, L. Heggelund, E. W. Nielsen, O. R. Geiran, M. Fung, and T. E. Mollnes. 2003. Mechanism of complement activation and its role in the inflammatory response after thoracoabdominal aortic aneurysm repair. Circulation 108: 849-856.
41. De Vries, B., S. J. Walter, C. J. Peutz-Kootstra, T. G. Wolfs, L. W. van Heurn, and W. A. Buurman. 2004. The mannose-binding lectin-pathway is involved in complement activation in the course of renal ischemia-reperfusion injury. Am. J. Pathol. 165: 1677-1688.